Literature DB >> 26149843

Outpatient Management of Febrile Children With Sickle Cell Disease.

Elizabeth Sokol1, Emily Obringer1, Brett Palama1, Joseph Hageman1, Radhika Peddinti2.   

Abstract

The electronic medical records at 2 children's hospitals were reviewed from June 1, 2011 to May 31, 2013 for all patients with sickle cell disease who presented with fever. Of a total of 390 blood cultures drawn, 11 cultures (2.8%) turned positive with only 1 (0.3%) growing a true pathogen. This culture turned positive in 13 hours. There were 154 patients who received exclusive outpatient management of fever. Fourteen patients (9.1%) completed 1 acute care visit, 16 patients (10.4%) completed 2 acute care visits, and 124 patients (80.5%) completed 3 acute care visits. Of those treated exclusively as outpatients, there was 1 positive culture that was considered a contaminant. Although the overall rate of positivity was low, this study confirms previous findings that pediatric blood cultures become positive with pathogens within 48 hours. Given the high rate of compliance and early time to positivity of true pathogens, we suggest that follow-up for the febrile sickle cell disease patients can be treated on an outpatient basis.
© The Author(s) 2015.

Entities:  

Keywords:  antibiotics; fever; sickle cell disease

Mesh:

Substances:

Year:  2015        PMID: 26149843     DOI: 10.1177/0009922815594345

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

1.  Time to Positive Blood and Cerebrospinal Fluid Cultures in Febrile Infants ≤60 Days of Age.

Authors:  Elizabeth R Alpern; Nathan Kuppermann; Stephen Blumberg; Genie Roosevelt; Andrea T Cruz; Lise E Nigrovic; Lorin R Browne; John M VanBuren; Octavio Ramilo; Prashant Mahajan
Journal:  Hosp Pediatr       Date:  2020-09

2.  Prevalence of Serious Bacterial Infections in Children with Sickle Cell Disease at King Abdulaziz Hospital, Al Ahsa.

Authors:  Manal A Alsaif; Moshtag Abdulbaqi; Khalid Al Noaim; Mustafa Aghbari; Muneera Alabdulqader; Joan L Robinson
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.